Want to see IN:NEULANDLAB full AI Analyst Report?
Neuland Laboratories Ltd. (NEULANDLAB) Revenue
Neuland Laboratories Ltd. Revenue
Neuland Laboratories Ltd. had a revenue of 6.42B in the quarter ending Jun 30, 2026, with -17.35%. This bring the company's revenue in the last twelve months to 23.72B, Increased 17.24%. In the fiscal year ending Mar 31, 2026, Neuland Laboratories Ltd. had annual revenue of 20.23B with 41.04% growth.
- Revenue (ttm)
- 23.72B
- Revenue Growth
- 78.33%
- P/S Ratio
- 12.49
- Revenue/Employee
- INR 12,312,753
- Employees
- 1,643
- Market Cap
- INR 252.76B
Revenue Chart
Neuland Laboratories Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 20.23B | 5.89B | 41.04% |
| Mar 31, 2025 | 14.34B | -812.81M | -5.36% |
| Mar 31, 2024 | 15.16B | 3.55B | 30.56% |
| Mar 31, 2023 | 11.61B | 2.38B | 25.73% |
| Mar 31, 2022 | 9.23B | 51.57M | 0.56% |
| Mar 31, 2021 | 9.18B | 1.79B | 24.18% |
| Mar 31, 2020 | 7.39B | 802.45M | 12.17% |
| Mar 31, 2019 | 6.59B | 1.48B | 28.99% |
| Mar 31, 2018 | 5.11B | -547.53M | -9.68% |
| Mar 31, 2017 | 5.66B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:NEULANDLAB | 23.72B |
| IN:AUROPHARMA | 348.91B |
| IN:DIVISLAB | 112.30B |
| IN:ALIVUS | 11.90B |
| IN:GRANULES | 56.18B |
| IN:LAURUSLABS | 72.70B |